Yoshimasa Sasabuchi

Title: Innovations of Yoshimasa Sasabuchi

Introduction

Yoshimasa Sasabuchi is a notable inventor based in Ikoma, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target angiogenesis and vascular permeability. With a total of three patents to his name, his work is recognized for its potential impact on medical treatments.

Latest Patents

Sasabuchi's latest patents include innovative compounds featuring a 4-pyridylalkylthio group as a substituent. These compounds are designed to treat diseases associated with angiogenesis or increased vascular permeability. The specific formulas he has developed include variations where A can be an aromatic five-membered heterocycle or benzene, and B is an alkylene. The compounds also incorporate various substituents such as hydrogen, hydroxyl, alkoxy, and more, showcasing a diverse range of chemical possibilities.

Career Highlights

Throughout his career, Yoshimasa Sasabuchi has been associated with Santen Pharmaceutical Co., Ltd., where he has contributed to groundbreaking research and development in the pharmaceutical industry. His expertise in creating compounds that address critical health issues has positioned him as a valuable asset in his field.

Collaborations

Sasabuchi has worked alongside talented colleagues such as Takahiro Honda and Hisashi Tajima. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.

Conclusion

Yoshimasa Sasabuchi's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments, particularly in addressing diseases related to angiogenesis.